159 related articles for article (PubMed ID: 2029500)
1. Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats.
Russell JC; Dolphin PJ; Hameed M; Stewart B; Koeslag DG; Rose-Kahn G; Bar-Tana J
Arterioscler Thromb; 1991; 11(3):602-9. PubMed ID: 2029500
[TBL] [Abstract][Full Text] [Related]
2. The effect of beta,beta'-tetramethylhexadecanedioic acid (MEDICA 16) on plasma very-low-density lipoprotein metabolism in rats: role of apolipoprotein C-III.
Frenkel B; Bishara-Shieban J; Bar-Tana J
Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):409-14. PubMed ID: 8135749
[TBL] [Abstract][Full Text] [Related]
3. Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats.
Bar-Tana J; Rose-Kahn G; Frenkel B; Shafer Z; Fainaru M
J Lipid Res; 1988 Apr; 29(4):431-41. PubMed ID: 3392461
[TBL] [Abstract][Full Text] [Related]
4. The hypochylomicronemic effect of beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) is mediated by a decrease in apolipoprotein C-III.
Frenkel B; Mayorek N; Hertz R; Bar-Tana J
J Biol Chem; 1988 Jun; 263(17):8491-7. PubMed ID: 3372539
[TBL] [Abstract][Full Text] [Related]
5. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats.
Russell JC; Koeslag DG; Amy RM; Dolphin PJ
Arteriosclerosis; 1989; 9(6):869-76. PubMed ID: 2590065
[TBL] [Abstract][Full Text] [Related]
7. Reduction of hyperlipidemia in the LA/N-corpulent rat by dietary fish oil containing n-3 fatty acids.
Dolphin PJ; Amy RM; Koeslag DG; Limoges BF; Russell JC
Biochim Biophys Acta; 1988 Oct; 962(3):317-29. PubMed ID: 3167083
[TBL] [Abstract][Full Text] [Related]
8. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy.
Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V
Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
10. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
11. Hypolipidemic, antiobesity, and hypoglycemic-hypoinsulinemic effects of beta,beta'-methyl-substituted hexadecanedioic acid in sand rats.
Tzur R; Rose-Kahn G; Adler JH; Bar-Tana J
Diabetes; 1988 Dec; 37(12):1618-24. PubMed ID: 3056760
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
13. Hypersecretion of VLDL, but not HDL, by hepatocytes from the JCR:LA-corpulent rat.
Vance JE; Russell JC
J Lipid Res; 1990 Aug; 31(8):1491-501. PubMed ID: 2280189
[TBL] [Abstract][Full Text] [Related]
14. Independence of myocardial disease in the JCR:LA-corpulent rat on plasma cholesterol concentration.
Russell JC; Koeslag DG; Amy RM; Dolphin PJ
Clin Invest Med; 1991 Aug; 14(4):288-95. PubMed ID: 1782727
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
16. Effects of castration and testosterone administration on serum lipoproteins and their apoproteins in male spontaneously hypertensive rat.
Takeuchi N; Go S; Murase M; Nomura Y; Takase H; Uchida K
Endocrinology; 1986 May; 118(5):1787-94. PubMed ID: 3084207
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
19. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Olsson AG; Lang PD
Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
[TBL] [Abstract][Full Text] [Related]
20. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
